1. Katayama H，Yamaguchi K，Kozuka T，et al. Adverse reaction to ionic and non-ionic contrast media. Radiology，1990，175（3）：621-628

2. Yamaguchi K，Katayama H，Takashima T，et al. Prediction of severe adverse reaction to ionic and non-ionic contrast media in Japan-evaluation of pretesting-a report from the Japanese Committee on the safety of Contrast Media. Radiology，1991，178（2）：363-367

3. Lee RC，Teng MMH，Wang SR. The value of pretesting in the use of iodinated contrast media. Chinese Journal of Radiology，1997，22（5）：189-192

4. Thomsen HS，Morcos SK，Members of Contrast Media Safety Committee of European Society of Urogenital Radiology（ESUR）. Management of acute reaction to contrast media. Eur Radiol，2004，14：476-481

5. Wild S，Roglic G，Green A，et al. Global prevalence of diabetes：estimates for the year 2000 and projections for 2030. Diabetes Care，2004，27：1047-1053

6. Coresh J，Byrd-Holt D，Astor BC，et al. Chronic kidney disease awareness，prevalence，and trends among U. S. adults，1999 to 2000. J Am Soc Nephrol，2005，16：180-188

7. Lysaght MJ. Maintenance dialysis population dynamics：current trends and long-term implications. J Am Soc Nephrol，2003，13（suppl）：S37-S40

8. Dangas G，Iakovou I，Nikolsky E，et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol，2005，95：13-19

9. Cochran ST，Bomyea K，Sayre JW. Trends in adverse events afterⅣadministration of contrast media. Am J Roentgenol，2001，176：1385-1388

10. Okada S，Katagiri K，Kumazaki T，et al. Safety of gadolinium contrast agent in hemodialysis patients. Acta Radiologica，2001，42：339

11. Aspelin P，Aubry P，Fransson SG，et al. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med，2003，348：491-499

12. Sadowski EA，Bennett LK，Chan MR，et al. Nephrogenic Systemic Fibrosis：Risk Factors and Incidence Estimation. Radiology，2007，243：148-157